Skip to search formSkip to main contentSkip to account menu

10 ML panitumumab 20 MG/ML Injection [Vectibix]

Known as: PANITUMUMAB 200 mg in 10 mL INTRAVENOUS SOLUTION [Vectibix], Vectibix 200 MG in 10 ML Injection, Vectibix 200 MG per 10 ML Injection 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (1)

10 ML panitumumab 20 MG/ML Injection
InjectionSodium AcetateSodium ChlorideVectibix

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Indications et prise en charge des effets secondaires des biothérapies anti-EGFR
Deux anticorps anti-EGFR (epidermal growth factor receptor), le cetuximab (Erbitux®) et le panitumumab (Vectibix®), et un… 
2012
2012
Klinický registr CORECT
Klinický registr CORECT vznikl v polovině roku 2011 sloucenim do te doby uspěsných registrů Avastin a Erbitux a rozsiřenim o… 
2009
2009
[Position statement of the Hungarian Radiotherapy and Oncology College on the insurance coverage of Vectibix (panitumumab)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)